drugset / Trial / NCT01366664
A Pharmacodynamic Study of Dapoxetine Concomitantly Administered in Participants Taking Terazosin
RandomizedCrossoverTriple-blindTreatment
Summary
The purpose of this study is to assess the pharmacodynamics (the actions or effects a drug has on the body), pharmacokinetics (blood levels), safety, and tolerability of dapoxetine 60 mg when concomitantly administered in participants taking terazosin.
Timeline
- Start
- 2011-04
- Primary completion
- 2012-04
- Completion
- 2012-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dapoxetine | Small molecule | 60 mg | Oral |
| Background | Terazosin | Small molecule | 2 mg | Oral |
| Background | Terazosin | Small molecule | 5 mg | Oral |
| Background | Terazosin | Small molecule | 10 mg | Oral |